Holding(s) in Company

AI SummaryClose X

Trevor Reginald has notified Roquefort Therapeutics PLC of a change in his major holding, reducing his voting rights from a previous position of 6.5% to 2.4%, which equates to 3,805,076 shares. This acquisition or disposal of voting rights occurred on November 24, 2025, and the issuer was notified on the same day. The notification indicates that Trevor Reginald is not controlled by any other entity and does not control any other undertakings holding an interest in the issuer.

Disclaimer*

UK 100

Latest directors dealings